Understanding the 500 Percent Price Increase of Pfizer’s COVID Vaccine
During a 2021 earnings call with stockholders, Pfizer Chief Financial Officer Frank D’Amelio discussed how the company was using “pandemic pricing” to charge $19.50 per COVID-19 vaccine dose, a product it expected to make $15 billion on in 2021. “[There’s] significant opportunity for those margins to improve once we get beyond the pandemic environment that […]
Pfizer Poised to Dominate U.S. Market for COVID-19 Biologics
Last week was a bad one for COVID-19 biologics produced by Moderna, Inc. and Johnson & Johnson, Inc. (J&J). News reports began filtering out about new research from the U.S. Centers for Disease Control and Prevention (CDC), which were published on Apr. 5, 2021 in the journal JAMA and revealed that people who receive Moderna’s […]
